Rafael Padilla, CEO of pharmaceuticals company, Fagron, discusses healthcare innovation, obesity drug safety, and the company's growth strategy amid global pricing pressures. Michigan fires head coach ...

Fagron, the global leader in pharmaceutical compounding, has reinforced its EMEA position with the acquisitions of a book of business from Amara (Poland) and Magilab (Hungary). These deals support ...

In the period from 3 November 2025 through 7 November 2025, Fagron purchased 45,000 of its owns shares at an average price of €20.4413 per share corresponding to a total amount of €919,856.70. These ...

In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to ...

Precision medicine helps healthcare professionals design medical treatment for individuals for decades. And biomarker matching therapies has shown effective for survival rate improvement (1). In a ...

Genomic testing is one method your doctor can use to predict how your cancer will grow and which treatments might work best against it. It's sometimes called "DNA sequencing." The test looks at all ...

The platform is called Nucleus Embryo, and according to the company, it enables couples to upload and analyze up to 20 embryo DNA files from their chosen IVF clinic. Uploaded embryo files are ...

Fagron, the leading global player in pharmaceutical compounding, held its annual general shareholders meeting today, where all the voting items were approved. The annual general meeting approved, ...

Fagron, a Belgian pharmaceutical compounding leader, has resolved previous market concerns and provided optimistic 2025-2030 guidance, projecting significant revenue and margin growth. The company ...

Fagron, the leading global player in pharmaceutical compounding, today publishes its annual report 2024. Discussion of the annual report and the approval of the financial statements will be put on the ...

Last week, Founders Fund partner Delian Asparouhov realized he hadn’t checked on his genetics in a while. He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that ...